In this system, I am using JavaScript. Please use after you enable the JavaScript.
"; contents += addScript; } } } return contents; } }); })(jQuery); //--> "; contents += addScript; } } } return contents; } }); })(jQuery); //-->
to Contents , 本文へ
Koji Sato
Career Summary, Positions, and Assignments
Apr. 1991
Joined Daiichi Pharmaceutical Company, Limited
Apr. 2019
Vice President of CMC Planning Department, Pharmaceutical Technology Unit of Daiichi Sankyo Co., Ltd.
Apr. 2021
Head of CMC Management Oncology and Head of Pharmaceutical Technology Unit of Daiichi Sankyo Inc.
Apr. 2023
Corporate officer of Daiichi Sankyo Co., Ltd.
Director of Daiichi Sankyo Holdings and Daiichi Sankyo Inc., Head of US Corporate Division, Head of Pharmaceutical Technology Unit and Head of CMC Management Oncology of Daiichi Sankyo Inc.
Apr. 2024
Corporate Officer of Daiichi Sankyo Co., Ltd.
Director of Daiichi Sankyo Holdings and Daiichi Sankyo Inc., Head of Project Lead and Head of Technology Unit of Daiichi Sankyo Inc.
Apr. 2025
Corporate Officer, Head of Technology Division and Head of Technology Supervisory Department of Technology Unit of Daiichi Sankyo Co., Ltd.
Apr. 2026
S
enior Executive Officer
,
Head of Technology Unit
and
Head of Technology Div
ision
,
Director of American Regent, Inc.
(to present)